Seoul, South Korea

Chi Man Song

USPTO Granted Patents = 5 


 

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2012-2019

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Chi Man Song: Innovator in Anticancer Compounds

Introduction

Chi Man Song is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anticancer agents. With a total of 5 patents, his work focuses on innovative compounds that have the potential to treat various tumor diseases.

Latest Patents

Among his latest patents, one notable invention is a novel pyrimidine-4-carboxylic acid derivative that exhibits anticancer activity. This compound is useful as a drug for treating and preventing tumor diseases. Another significant patent involves a 2,3,5-substituted thiophene compound that acts as a protein kinase inhibitor. This invention includes an anticancer agent featuring the compound as an active ingredient, along with a method for preparing it.

Career Highlights

Chi Man Song has worked with esteemed organizations such as the Korea Institute of Science and Technology and the Daegu-Gyeongbuk Medical Innovation Foundation. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Throughout his career, Chi Man Song has collaborated with notable colleagues, including Tae Bo Sim and Han Na Cho. These partnerships have fostered innovation and the exchange of ideas in the field of medicinal chemistry.

Conclusion

Chi Man Song's contributions to the development of anticancer compounds highlight his role as a significant inventor in the field. His innovative work continues to pave the way for advancements in cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…